What's new

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 43, Status: Authorised

Mar 5, 2025 - 14:03
 0
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 43, Status: Authorised
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 43, Status: Authorised
Read More

Tags:

Previous Article

Minutes - PDCO minutes of the 12-15 November 2024 meeting

Next Article

Pratt & Whitney Successfully Tests Rotating Detonation Engine

Related Posts

EMEA-003468-PIP01-23

EMEA-003468-PIP01-23

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0